subject area of
- A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer Academic Article
- ATM regulates proteasome-dependent subnuclear localization of TRF1, which is important for telomere maintenance Academic Article
- Glucosamine-Induced Endoplasmic Reticulum Stress Promotes ApoB100 Degradation Academic Article
- Proteasomal Regulation of Cardiac Hypertrophy Academic Article
- Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle Academic Article
- Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis Academic Article
- Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world” Academic Article
- The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors Academic Article
- The Ubiquitin–Proteasome System and Cardiovascular Disease Academic Article